These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Arteriosclerosis--nicotinic acid therapy. 3. Lipolytic effects of nicotinic acid and its derivatives]. Lundholm L Lakartidningen; 1971 Apr; 68(15):1746-9. PubMed ID: 5577245 [No Abstract] [Full Text] [Related]
5. Management of the hyperlipidemic patient. Berkowitz D Med Clin North Am; 1973 Jul; 57(4):881-92. PubMed ID: 4576152 [No Abstract] [Full Text] [Related]
6. The effect of hypolipidemic drugs on plasma lipoproteins. Levy RI Annu Rev Pharmacol Toxicol; 1977; 17():499-510. PubMed ID: 326171 [No Abstract] [Full Text] [Related]
7. Lipid-lowering drugs. Med Lett Drugs Ther; 1975 Jun; 17(12):49-50. PubMed ID: 1128443 [No Abstract] [Full Text] [Related]
8. [The treatment of essential hyperlipidemia with clofibrate]. Reuter W; Seifert A Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:184-7. PubMed ID: 4918619 [No Abstract] [Full Text] [Related]
9. Results of treatment of hyperlipidemias: long-term compliance and effect of lipid metabolism. Frantz ID Adv Exp Med Biol; 1977; 82():649-55. PubMed ID: 920422 [No Abstract] [Full Text] [Related]
10. [Dietetic and drug therapy of hyperlipidemias and hyperlipoproteinemia]. Huth K; Blumenthal J; Schmahl FW Med Klin; 1973 Aug; 68(34):1089-97. PubMed ID: 4790868 [No Abstract] [Full Text] [Related]
11. The mechanism of action of clofibrate and tetranicotinoylfructose (Bradilan) on the kinetics of plasma free fatty acid and triglyceride transport in type IV and type V hypertriglyceridaemia. Kissebah AH; Adams PW; Harrigan P; Wynn V Eur J Clin Invest; 1974 Jun; 4(3):163-74. PubMed ID: 4838694 [No Abstract] [Full Text] [Related]
12. Cholestyramine for elevated serum cholesterol. Med Lett Drugs Ther; 1974 Apr; 16(8):33-4. PubMed ID: 4362570 [No Abstract] [Full Text] [Related]
13. Symposium on arteriosclerotic heart disease. Medical management of angina pectoris. Likoff W Geriatrics; 1972 May; 27(5):91-8. PubMed ID: 5022811 [No Abstract] [Full Text] [Related]
14. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] on lipid metabolism. I. Effect on blood lipids in normal and hyperlipemic rats]. Maroto ML; Priego JG; Piña M; Catalán RE Arch Farmacol Toxicol; 1978 Apr; 4(1):25-7. PubMed ID: 697396 [No Abstract] [Full Text] [Related]
16. The common hyperlipoproteinemias: an understanding of disease mechanisms and their control. Fisher WR; Truitt DH Ann Intern Med; 1976 Oct; 85(4):497-508. PubMed ID: 184730 [TBL] [Abstract][Full Text] [Related]
17. [Drug therapy of dyslipidemias]. Lenzi S Minerva Med; 1975 Oct; 66(66):3479-82. PubMed ID: 1178140 [No Abstract] [Full Text] [Related]
18. [Treatment of hyperlipoproteinemia in relation to recent classifications]. Cloarec M Minerva Med; 1971 Sep; 62(72):3452-5. PubMed ID: 5097215 [No Abstract] [Full Text] [Related]
19. [Drug therapy of hyperlipemia. Role of drugs at the disposition of general practitioners]. Pometta D Ther Umsch; 1970 Mar; 27(3):128-32. PubMed ID: 5437609 [No Abstract] [Full Text] [Related]